Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL: https://www.bionews.org.uk/page_91809

Gene therapy improves vision in rare hereditary blindness condition

17 August 2009
Appeared in BioNews 521

A phase I clinical trial in the US has successfully used gene therapy to improve vision in individuals suffering from a rare form of hereditary blindness. The promising results of this trial pave the way for future trials and may eventually lead to a cure for several forms of congenital blindness.

The study, supported by the US National Eye Institute (NEI), was conducted at the University of Pennsylvania and the University of Florida. Three individuals aged 22, 24 and 25, who were registered as legally blind since birth due to a condition called Leber's congenital amaurosis (LCA), were treated with gene therapy to correct the genetic defect that caused their loss of vision. One year after treatment there was no indication of negative side effects caused by an immune response to the corrective DNA in any of the patients and, although the patients' ability to read an eye chart was unchanged, they were all able to detect dim lights that they could not see before the therapy. One patient was reportedly able to read an illuminated digital clock on the dashboard of a car for the first time.

Professor Artur Cideciyan, a leading member of the research team, said: 'At one year... [this] gene therapy appears to be safe and leads to a stable visual improvement in the patients studied. We are cautiously optimistic about these results and look forward to additional reports that address the key issues of safety and effectiveness'.

The three patients all suffered from LCA due to defects in a gene called RPE65, which is makes a form of vitamin A that is essential for the functioning of light-detecting cells in the eye. The researchers used a genetically engineered virus as a vehicle to deliver corrected versions of RPE65 to certain areas of the eye where these cells were still intact enough to be good candidates for repair. They found that the woman who gained the ability to read the car clock showed signs that her brain was re-training itself to use only the corrected areas of her eye. Professor Samuel Jacobson, who led the trial, commented that 'this... finding shows that over time, a person visually adapted to gene therapy in a meaningful way. As we continue our studies, we will look more closely at whether these slow visual gains could be accelerated with visual training'.

The three patients will continue to be monitored for several years to ensure the therapy's safety and to determine how long-lasting the improvements in their vision are. Further trials of this therapy are also underway. Dr Paul Sieving, director of the NEI, said: 'These results are very significant because they represent one of the first steps toward the clinical use of gene therapy for an inherited form of blindness. I anticipate that it is only a matter of time before similar techniques will be applied to other genetic diseases affecting vision.'

SOURCES & REFERENCES
Gene therapy improves vision in Leber Amaurosis
Medpage Today |  12 August 2009
Gene therapy ‘leads to stable improvements in sight’
The Daily Telegraph |  14 August 2009
Lasting benefits seen in gene therapy for blindness
Reuters |  12 August 2009
Vision researchers see unexpected gain one year into blindness trial - Rebecca
ScienceDaily |  14 August 2009
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
27 June 2011 - by Dr Nadeem Shaikh 
A group of US scientists has successfully used a virus to deliver genes into monkey retinas that could potentially restore damaged photoreceptor cells. The findings could lead to gene therapies being developed to treat blindness and other eye conditions in humans...
7 March 2011 - by Dr Lux Fatimathas 
American researchers have successfully created immune cells resistant to HIV. T cells, which are the main target of HIV, were isolated from six HIV positive patients and genetically manipulated to confer resistance. The cells were injected back into the same patients and were able to survive and multiply...
1 November 2009 - by Dr Marianne Kennedy 
US doctors have used gene therapy to restore significant vision in 12 patients who were previously blinded by a disease called Leber's congenital amaurosis. The study, conducted by researchers at the Children`s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, was published online in the Lancet on 24 October....
28 April 2008 - by Ailsa Stevens 
Four people with a rare inherited condition which leads to blindness in childhood have reportedly experienced improved vision after taking part in the world's first trials of an experimental gene therapy, according to two independent studies published online in the New England Journal of Medicine. Professor Robin...
9 May 2007 - by Ailsa Stevens 
Researchers at University College London are the first in the world to attempt to use gene therapy to treat a rare inherited condition which leads to blindness in childhood. The disease, known as Leber Congenital Syndrome (LCS), is caused by an abnormality in the RPE65 gene, which...
30 April 2001 - by BioNews 
Gene therapy has enabled dogs born blind because of an inherited disorder to have some of their sight restored. This is the first time that gene therapy of this type has proved to be successful in a large animal. The achievement might mean that the technique could be adapted to...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.